Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Nov;71(11):8109–8115. doi: 10.1128/jvi.71.11.8109-8115.1997

Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.

E L Parr 1, M B Parr 1
PMCID: PMC192266  PMID: 9343160

Abstract

We investigated the protective role of antibodies in vaginal secretions of mice that were immune to vaginal challenge with herpes simplex virus type 2 (HSV-2). Unfractionated vaginal immunoglobulins from immune and nonimmune mice and affinity-purified immunoglobulin G (IgG) and secretory IgA (S-IgA) from immune secretions were adjusted to their concentrations in vivo. Wild-type HSV-2 was incubated in the immunoglobulin preparations for 15 min in vitro, followed by inoculation into vaginae of nonimmune mice. HSV-2 was neutralized by unfractionated antibody and purified IgG from immune secretions but not by unfractionated nonimmune antibody or by purified immune S-IgA. The protective effect of IgG in vivo was investigated by passively transferring purified serum IgG from immune and nonimmune donors to nonimmune recipients before vaginal challenge infection. Immune IgG significantly reduced the percentage of vaginal epithelium infected, concentrations of shed virus protein in the vaginal lumen, and illness scores, even though the viral antibody titers in serum and vaginal secretions of recipient mice at the time of challenge were only 29 and 8%, respectively, of those in actively immunized mice. Additionally, removal of vaginal secretions from immune mice 10 min before vaginal challenge with HSV-2 significantly increased the concentration of shed virus protein in the vaginal lumen after challenge. Collectively, the data indicate that IgG antibody in vaginal secretions of immune mice provides early protection against vaginal challenge infection, probably by neutralizing virus in the vaginal lumen. In contrast, S-IgA antibody contributed relatively little to immune protection of the vagina.

Full Text

The Full Text of this article is available as a PDF (303.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allardyce R., Rademaker M. Female genital tract immunity and infertility after oral vaccination with sperm antigens in mice. Adv Exp Med Biol. 1987;216B:1807–1813. [PubMed] [Google Scholar]
  2. Baker D. A., Plotkin S. A. Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone. Proc Soc Exp Biol Med. 1978 Jun;158(2):131–134. doi: 10.3181/00379727-158-40156. [DOI] [PubMed] [Google Scholar]
  3. Briese V., Pohl W. D., Noack K., Tischner H., Waldman R. H. Influenza specific antibodies in the female genital tract of mice after oral administration of live influenza vaccine. Arch Gynecol. 1987;240(3):153–157. doi: 10.1007/BF00207710. [DOI] [PubMed] [Google Scholar]
  4. Corbeil L. B. Vaccination strategies against Tritrichomonas foetus. Parasitol Today. 1994 Mar;10(3):103–106. doi: 10.1016/0169-4758(94)90009-4. [DOI] [PubMed] [Google Scholar]
  5. Coughlan B. M., Skinner G. R. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus. Br J Obstet Gynaecol. 1977 Aug;84(8):622–629. doi: 10.1111/j.1471-0528.1977.tb12666.x. [DOI] [PubMed] [Google Scholar]
  6. Di Tommaso A., Saletti G., Pizza M., Rappuoli R., Dougan G., Abrignani S., Douce G., De Magistris M. T. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun. 1996 Mar;64(3):974–979. doi: 10.1128/iai.64.3.974-979.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drew M. D., Estrada-Correa A., Underdown B. J., McDermott M. R. Vaccination by cholera toxin conjugated to a herpes simplex virus type 2 glycoprotein D peptide. J Gen Virol. 1992 Sep;73(Pt 9):2357–2366. doi: 10.1099/0022-1317-73-9-2357. [DOI] [PubMed] [Google Scholar]
  8. Eis-Hübinger A. M., Schmidt D. S., Schneweis K. E. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J Gen Virol. 1993 Mar;74(Pt 3):379–385. doi: 10.1099/0022-1317-74-3-379. [DOI] [PubMed] [Google Scholar]
  9. Estrada A., McDermott M. R., Underdown B. J., Snider D. P. Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies. Vaccine. 1995 Jul;13(10):901–907. doi: 10.1016/0264-410x(95)00012-p. [DOI] [PubMed] [Google Scholar]
  10. Franco M. A., Greenberg H. B. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol. 1995 Dec;69(12):7800–7806. doi: 10.1128/jvi.69.12.7800-7806.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gallichan W. S., Rosenthal K. L. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology. 1996 Oct 15;224(2):487–497. doi: 10.1006/viro.1996.0555. [DOI] [PubMed] [Google Scholar]
  12. Gallichan W. S., Rosenthal K. L. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine. 1995 Nov;13(16):1589–1595. doi: 10.1016/0264-410x(95)00100-f. [DOI] [PubMed] [Google Scholar]
  13. Hazama M., Mayumi-Aono A., Miyazaki T., Hinuma S., Fujisawa Y. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. Immunology. 1993 Apr;78(4):643–649. [PMC free article] [PubMed] [Google Scholar]
  14. Heritage P. L., Loomes L. M., Jianxiong J., Brook M. A., Underdown B. J., McDermott M. R. Novel polymer-grafted starch microparticles for mucosal delivery of vaccines. Immunology. 1996 May;88(1):162–168. doi: 10.1046/j.1365-2567.1996.d01-639.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Holmgren J. Mucosal immunity and vaccination. FEMS Microbiol Immunol. 1991 Dec;4(1):1–9. doi: 10.1111/j.1574-6968.1991.tb04964.x. [DOI] [PubMed] [Google Scholar]
  16. Kraehenbuhl J. P., Neutra M. R. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev. 1992 Oct;72(4):853–879. doi: 10.1152/physrev.1992.72.4.853. [DOI] [PubMed] [Google Scholar]
  17. Lee E. J., Kaminchik J., Hankins W. D. Expression of xenotropic-like env RNA sequences in normal DBA/2 and NZB mouse tissues. J Virol. 1984 Jul;51(1):247–250. doi: 10.1128/jvi.51.1.247-250.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lehner T., Wang Y., Cranage M., Bergmeier L. A., Mitchell E., Tao L., Hall G., Dennis M., Cook N., Brookes R. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med. 1996 Jul;2(7):767–775. doi: 10.1038/nm0796-767. [DOI] [PubMed] [Google Scholar]
  19. McDermott M. R., Brais L. J., Evelegh M. J. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J Gen Virol. 1990 Jul;71(Pt 7):1497–1504. doi: 10.1099/0022-1317-71-7-1497. [DOI] [PubMed] [Google Scholar]
  20. McDermott M. R., Brais P. L., PLoettsche G. C., Evelegh M. J., Goldsmith C. H. Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes. Arch Virol. 1987;93(1-2):51–68. doi: 10.1007/BF01313893. [DOI] [PubMed] [Google Scholar]
  21. Milligan G. N., Bernstein D. I. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology. 1995 Oct 1;212(2):481–489. doi: 10.1006/viro.1995.1506. [DOI] [PubMed] [Google Scholar]
  22. Milligan G. N., Bernstein D. I. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology. 1995 Jan 10;206(1):234–241. doi: 10.1016/s0042-6822(95)80038-7. [DOI] [PubMed] [Google Scholar]
  23. Murdin A. D., Su H., Klein M. H., Caldwell H. D. Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect Immun. 1995 Mar;63(3):1116–1121. doi: 10.1128/iai.63.3.1116-1121.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Muster T., Ferko B., Klima A., Purtscher M., Trkola A., Schulz P., Grassauer A., Engelhardt O. G., García-Sástre A., Palese P. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol. 1995 Nov;69(11):6678–6686. doi: 10.1128/jvi.69.11.6678-6686.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O'Hagan D. T., Palin K., Davis S. S., Artursson P., Sjöholm I. Microparticles as potentially orally active immunological adjuvants. Vaccine. 1989 Oct;7(5):421–424. doi: 10.1016/0264-410x(89)90156-4. [DOI] [PubMed] [Google Scholar]
  26. Oggioni M. R., Manganelli R., Contorni M., Tommasino M., Pozzi G. Immunization of mice by oral colonization with live recombinant commensal streptococci. Vaccine. 1995;13(8):775–779. doi: 10.1016/0264-410x(94)00060-z. [DOI] [PubMed] [Google Scholar]
  27. Parr E. L., Bozzola J. J., Parr M. B. Purification and measurement of secretory IgA in mouse milk. J Immunol Methods. 1995 Mar 27;180(2):147–157. doi: 10.1016/0022-1759(94)00310-s. [DOI] [PubMed] [Google Scholar]
  28. Parr E. L., Parr M. B. Deposition of C3 on bacteria in the mouse uterus after mating. J Reprod Immunol. 1988 Mar;12(4):315–319. doi: 10.1016/0165-0378(88)90016-2. [DOI] [PubMed] [Google Scholar]
  29. Parr M. B., Kepple L., McDermott M. R., Drew M. D., Bozzola J. J., Parr E. L. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest. 1994 Mar;70(3):369–380. [PubMed] [Google Scholar]
  30. Simmons A., Nash A. A. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J Infect Dis. 1987 Apr;155(4):649–654. doi: 10.1093/infdis/155.4.649. [DOI] [PubMed] [Google Scholar]
  31. Slifka M. K., Ahmed R. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 1996 Oct;4(10):394–400. doi: 10.1016/0966-842X(96)10059-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sparling P. F., Elkins C., Wyrick P. B., Cohen M. S. Vaccines for bacterial sexually transmitted infections: a realistic goal? Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2456–2463. doi: 10.1073/pnas.91.7.2456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Srinivasan J., Tinge S., Wright R., Herr J. C., Curtiss R., 3rd Oral immunization with attenuated Salmonella expressing human sperm antigen induces antibodies in serum and the reproductive tract. Biol Reprod. 1995 Aug;53(2):462–471. doi: 10.1095/biolreprod53.2.462. [DOI] [PubMed] [Google Scholar]
  34. Staats H. F., Jackson R. J., Marinaro M., Takahashi I., Kiyono H., McGhee J. R. Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol. 1994 Aug;6(4):572–583. doi: 10.1016/0952-7915(94)90144-9. [DOI] [PubMed] [Google Scholar]
  35. Staats H. F., Nichols W. G., Palker T. J. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J Immunol. 1996 Jul 1;157(1):462–472. [PubMed] [Google Scholar]
  36. Teepe A. G., Allen L. B., Wordinger R. J., Harris E. F. Effect of the estrous cycle on susceptibility of female mice to intravaginal inoculation of herpes simplex virus type 2 (HSV-2). Antiviral Res. 1990 Oct-Nov;14(4-5):227–235. doi: 10.1016/0166-3542(90)90004-q. [DOI] [PubMed] [Google Scholar]
  37. Thapar M. A., Parr E. L., Parr M. B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology. 1990 May;70(1):121–125. [PMC free article] [PubMed] [Google Scholar]
  38. Underdown B. J., Schiff J. M. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol. 1986;4:389–417. doi: 10.1146/annurev.iy.04.040186.002133. [DOI] [PubMed] [Google Scholar]
  39. Ward M. E. The immunobiology and immunopathology of chlamydial infections. APMIS. 1995 Nov;103(11):769–796. doi: 10.1111/j.1699-0463.1995.tb01436.x. [DOI] [PubMed] [Google Scholar]
  40. Zhang X., Lou Y. H., Koopman M., Doggett T., Tung K. S., Curtiss R., 3rd Antibody responses and infertility in mice following oral immunization with attenuated Salmonella typhimurium expressing recombinant murine ZP3. Biol Reprod. 1997 Jan;56(1):33–41. doi: 10.1095/biolreprod56.1.33. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES